Origen de la red de primer grado Ricardo Zwirtes.
Entidad | Tipo de entidad | Industria | |
---|---|---|---|
Public Company | Biotechnology | 27 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Ricardo Zwirtes a través de su red personal
Empresa | Sector | Personas relacionadas | Puesto principal |
---|---|---|---|
AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Public Communications Contact | |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal | |
MERCK & CO., INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Investor Relations Contact | |
PFIZER, INC. | Pharmaceuticals: Major | General Counsel | |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
BIOGEN INC. | Pharmaceuticals: Major | Comptroller/Controller/Auditor Sales & Marketing Corporate Officer/Principal Human Resources Officer | |
F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Microbion Corp.
Microbion Corp. Pharmaceuticals: MajorHealth Technology Microbion Corp. develops topical microbial therapeutic products. It safeguards human health by overcoming infections, antibiotic resistance, and microbial biofilms with safe, effective anti-infective products. The firm is developing MBN-101 as the first product in a new class for the treatment of antibiotic-resistant and difficult to treat infections. The company was founded by Brett H. Baker and is headquartered in Bozeman, MT. | Pharmaceuticals: Major | Director/Board Member | |
PhysIQ, Inc.
PhysIQ, Inc. Packaged SoftwareTechnology Services PhysIQ, Inc. provides proprietary predictive analytics for human physiology. It designs, develops and commercializes predictive analytics technologies to monitor the health of complex systems. The company was founded by Matt R. Pipke and Gary W. Conkright in 1999 and is headquartered in Naperville, IL. | Packaged Software | Director/Board Member | |
ALNYLAM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chairman Chief Tech/Sci/R&D Officer | |
Massachusetts Institute of Technology | College/University | Doctorate Degree Doctorate Degree Corporate Officer/Principal Doctorate Degree | |
University of Wisconsin | College/University | Undergraduate Degree | |
University of Florida | College/University | Undergraduate Degree | |
Universität zu Köln | College/University | Doctorate Degree | |
Technical University of Denmark | College/University | Chief Tech/Sci/R&D Officer | |
London School of Economics & Political Science | College/University | Graduate Degree | |
Weizmann Institute of Science | College/University | Doctorate Degree | |
NanoDimension Management Ltd.
NanoDimension Management Ltd. Investment ManagersFinance Nano Dimension Management Ltd is a venture capital firm founded in 2002 by Aymeric Sallin. The firm is headquartered in George Town. | Investment Managers | Private Equity Investor | |
Forbion Capital Partners Management Holding BV
Forbion Capital Partners Management Holding BV Investment ManagersFinance Forbion Capital Partners Management Holding BV (Forbion) is a Netherlands-based venture capital firm which was founded by Bart Bergstein. Headquartered in Naarden, the firm specializes in late-stage and early-stage clinical development programs to optimize the commercial potential of their investee company's technologies. | Investment Managers | Private Equity Investor | |
HEARTWARE INTERNATIONAL INC | Medical Specialties | General Counsel Human Resources Officer | |
Community Servings, Inc.
Community Servings, Inc. Services to the Health IndustryHealth Services Community Servings is a non-profit organization that provides food and nutrition programs to individuals and families living with critical and chronic illnesses. It offers meal delivery, nutrition services, and program initiatives, covering: job trainings, international advocacies, social enterprise, and sustainable agriculture. The company was founded in 1989 and is headquartered in Jamaica Plain, MA. | Services to the Health Industry | Director/Board Member | |
i2chem, Inc.
i2chem, Inc. SemiconductorsElectronic Technology i2chem, Inc. develops integrated microchemical systems based on silicon micro reactors. The firm is a startup company commercializing micro reactors for chemical applications. The company was founded by Klavs Jensen & Peter H. Seeberger in 2005 and is headquartered in Sunnyvale, CA. | Semiconductors | Founder | |
Athyrium Capital Management LP
Athyrium Capital Management LP Investment ManagersFinance Athyrium Capital Management LP (Athyrium) is an independent, SEC-registered investment advisor and hedge fund manager headquartered in New York City. The firm was founded by Jeffrey A. Ferrell in 2008 as Athyrium Capital Management LLC and converted from a Delaware limited liability company to a Delaware limited partnership in 2015. Athyrium provides advisory services on a discretionary basis to its clients, which may include specific tailored vehicles and pooled investment vehicles intended for sophisticated investors and institutional investors. | Investment Managers | Consultant / Advisor | |
Avastin | Chief Tech/Sci/R&D Officer | ||
FRACTYL HEALTH, INC. | Biotechnology | Director/Board Member Director/Board Member | |
Amphivena Therapeutics, Inc.
Amphivena Therapeutics, Inc. Drugstore ChainsRetail Trade Amphivena Therapeutics, Inc. provides drug discovery services. It develops tetravalent, T-cell redirecting bispecific antibodies for the treatment of hematologic malignancies. The firm’s’ lead drug candidate is AMV-564, a CD33/CD3-targeting treatment for acute myeloid leukemia (AML), which Amphivena is currently preparing to advance into clinical development. The company was founded by Jeanmarie Guenot in December 2012 and is headquartered in San Francisco, CA. | Drugstore Chains | Director/Board Member | |
Eloxx Pharmaceuticals Ltd.
Eloxx Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Eloxx Pharmaceuticals Ltd. provides biopharmaceutical research and development services. The firm specializes in the discovery, development, and commercialization of drug compounds for the treatment of genetic diseases. It focuses on the treatment of diseases caused by nonsense mutations, including Cystic fibrosis, Duchene Muscular Dystrophy, Usher syndrome, Ataxia-telangiectasia, Beta thalassemia, and Tay-Sachs Hurler syndrome. Its focus areas encompass clinical drug development and target drugs discovery programs. The company was founded by Silvia Noiman and Shmuel Tuvia in 2013 and is headquartered in Herzliya, Israel. | Pharmaceuticals: Major | Director/Board Member | |
Emulate, Inc.
Emulate, Inc. Drugstore ChainsRetail Trade Emulate, Inc. owns and operates Organs-on-Chips platform which acts as an automated human bioemulation platform for mimicking true human physiology. The firm's product responses to medicines, chemicals, and diseases can be predicted. The company was founded by James Coon, Donald Ingber and Geraldine Hamilton in July 2014 and is headquartered in Cambridge, MA. | Drugstore Chains | Director/Board Member | |
Raziel Therapeutics RT Ltd.
Raziel Therapeutics RT Ltd. Pharmaceuticals: MajorHealth Technology Raziel Therapeutics RT Ltd. develops innovative technology to treat obesity disease. It is developing RZL-12, is a potential first-in-class, injectable drug for the reduction of fat cell mass. the firm developed a novel drug (NCE) that after a single injection into subcutaneous fat, converts white adipose tissue (WAT) into brown adipose tissue-like. The company was founded by Shmuel A. Ben-Sasson in 2012 and is headquartered in Jerusalem, Israel. | Pharmaceuticals: Major | Director/Board Member | |
Lyndra Therapeutics, Inc.
Lyndra Therapeutics, Inc. Packaged SoftwareTechnology Services Lyndra Therapeutics, Inc. develops software technology for oral drug formulations. It offers pharmacology, therapeutic impact, reduced pill burden, and reduced care giver burden. The company was founded by Amy W. Schulman, Carlo Giovanni Traverso, Andrew Bellinger, and Robert S. Langer Jr. in 2015 and is headquartered in Watertown, MA. | Packaged Software | Founder Director/Board Member | |
KEROS THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
CathWorks Ltd.
CathWorks Ltd. Medical SpecialtiesHealth Technology CathWorks Ltd. develops medical devices for the interventional cardiology market. Its technology is based on processing visual information and automatic multi-layered algorithms. The company was founded by Guy Lavi and Ifat Lavi in 2013 and is headquartered in Raanana, Israel. | Medical Specialties | Director/Board Member | |
GENENTA SCIENCE S.P.A. | Pharmaceuticals: Major | Director/Board Member | |
Essential Pharmaceuticals LLC
Essential Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Part of Intas Pharmaceuticals Ltd., Essential Pharmaceuticals LLC is a company that manufactures and markets pharmaceutical products. The company is based in Durham, NC. The company was founded in 2006. Emma Jane Johnson has been the CEO of the company since 2023. Essential Pharmaceuticals was acquired by Accord Healthcare, Inc. on July 26, 2017. | Pharmaceuticals: Major | Chairman | |
DECIPHERA PHARMACEUTICALS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
ELOXX PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member | |
Essential Pharmaceuticals Ltd.
Essential Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Essential Pharmaceuticals Ltd. manufactures pharmaceutical products. The company was founded on November 24, 2010 and is headquartered in Egham, the United Kingdom. | Pharmaceuticals: Major | Chairman | |
Gyrus Capital SA | Investment Managers | Private Equity Investor | |
Enclear Therapies, Inc.
Enclear Therapies, Inc. Pharmaceuticals: MajorHealth Technology Enclear Therapies, Inc. develops and manufactures novel device-based therapies to treat patients. The firm device is developed to treat and halt the progression of neurodegenerative diseases by removing toxic proteins known to drive pathology. The company was founded by Anthony R. DePasqua, Jonathan J. Fleming, Kasper Roet, William B. Gormley and Kevin Eggan and is headquartered in Newburyport, MA. | Pharmaceuticals: Major | Director/Board Member | |
AMRYT PHARMA PLC | Pharmaceuticals: Major | Director/Board Member | |
NUVALENT, INC. | Biotechnology | Director/Board Member Director of Finance/CFO | |
Volastra Therapeutics, Inc.
Volastra Therapeutics, Inc. BiotechnologyHealth Technology Volastra Therapeutics, Inc. develops novel therapies for patients with metastatic cancers. The company was founded by Lewis Cantley, Samuel Bakhoum and Olivier Elemento and is headquartered in Boston, MA. | Biotechnology | Director/Board Member Director/Board Member | |
F2g Inc. | Director/Board Member | ||
ICOSAVAX, INC. | Pharmaceuticals: Major | Director/Board Member |
Estadísticas
Internacional
Estados Unidos | 34 |
Israel | 6 |
Suiza | 3 |
Reino Unido | 3 |
Alemania | 2 |
Sectorial
Health Technology | 29 |
Consumer Services | 7 |
Finance | 6 |
Technology Services | 3 |
Retail Trade | 3 |
Operativa
Director/Board Member | 111 |
Corporate Officer/Principal | 39 |
Independent Dir/Board Member | 37 |
Undergraduate Degree | 21 |
Chairman | 19 |
Las relaciones más conectadas
Insiders | |
---|---|
Amy Schulman | 45 |
Patrick Volkert Vink | 30 |
Sapna R. Srivastava | 21 |
Zafrira Avnur | 20 |
Alexis Ji | 15 |
Teri Loxam | 14 |
Bernard Coulie | 13 |
Lawrence Knopf | 12 |
Paul Bolno | 12 |
Eric Moessinger | 12 |
Marc Schegerin | 11 |
Oliver Rosen | 9 |
Marc Elia | 9 |
Howard Bernstein | 8 |
Kyle Feldman | 7 |
- Bolsa de valores
- Insiders
- Ricardo Zwirtes
- Conexiones Empresas